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A new abnormal hemoglobin, Hb Kariya [a40 (0) Lys -+ Glu], with an amino acid substitution at the 
(Y&Z contact was discovered in a young Japanese man. This variant migrated to the anode faster than Hb 
A, being nearly the same as Hb I in electrophoretic mobility. It amounted to about 6% of the total 
hemoglobin of the hemolysate. This hemoglobin showed an increased oxygen affinity, decreased 
heme-heme interaction and a lowered 2,3-DPG effect. 
HemogIobin Kariya [cu40 (CS) Lys -+ Glu] 
1. INTRODUCTION 
In 1982, 14 carriers of abnormal hemoglobins 
were detected amongst 24000 inhabitants living in 
a southern sea-coast area of Aichi Prefecture 
situated in the central part of Japanese main island 
(Honshu) in the course of a mass screening hemo- 
globinopathy survey using isoelectric focusing 
(IEF) [l]. Among them there was an apparently 
healthy 19-year-old Japanese male who possessed a
fast-moving hemoglobin reminiscent of Hb I. 
Structural analysis of the hemoglobin disclosed a 
variant with an amino acid substitution of Lys + 
Glu at the 40th site of the cy chain, which had not 
been reported previously. We called it Hb Kariya 
after the name of the city where its carrier lived. 
The results of our study on structure and function 
of this hemoglobin are presented. 
2. MATERIALS AND METHODS 
Hematological studies were done by the conven- 
tional procedures. IEF was done on thin-layer 
(~1fi2 Contact High oxygen affinity 
ampholine-polyacrylamide gel (pH 6-9) as in [ 11. 
The detection of the abnormal polypeptide chain 
was made by 8 M urea-dissociation-cellulose ace- 
tate electrophoresis [2]. The erythrocyte 2,3-DPG 
content was measured by use of 2,3-DPG measure- 
ment kit (Sigma Lab.). Instability tests were done 
as in [3]. The Heinz body preparation test was 
done as in [4]. The hemoglobin composition of the 
hemolysate was evaluated by spectrometry at 
415 nm of eluates of isoelectrically focused 
hemoglobins. The Hb F content was determined 
by alkali denaturation [5]. The purification of the 
Hb fraction was done as in [6]. 
Oxygen equilibrium curves of the purified Hb’s 
were automatically determined in 0.05 M bis-Tris 
buffer (pH 7.45 and 6.95 containing 0.1 M Cl-) 
with or without 2,3-DPG (2 mM) at 25°C [7,8]. 
After deheminization with HCl-acetone, the 
globins were chromatographed on a CMC-column 
to isolate the abnormal cx chain [9]. The soluble 
fraction of the TPCK-tryptic digest of the a-chain 
was fingerprinted on cellulose thin-layer (Chroma- 
gram Sheet, Eastman-Kodak) [lo], eluted and the 
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peptides subjected to hydrolysis in constant- 
boiling HCI, The amino acid composition was 
analyzed in an automatic amino acid analyzer 
(Yanaco L-7). 
3. RESULTS 
Hematological features of the propositus were 
normal (RBC 477 x l@/pl, Hb 15.8 g/dl, Ht 
45.3%, retie. count 1.0070, Bil (T) 0.8 mg/dl). The 
erythrocyte 2,3-DPG level was almost normal: 
15.4~mollg Hb (normal range: 10.1-15.1). By 
IEF the abnormal Hb component focused more 
anodally than Hb A (fig. I), and constituted 6.1% 
of the total hemoglobins of the hemolysate. The 
Hb AZ content was 2.3% (normal range: 1.8-3.2) 
and the Hb F content was slightly increased: 1.6% 
(normal range: <l.l). An instability test of whole 
hemolysate was questionably positive, but the 
purified sample of Hb Kariya showed an unam- 
biguously positive result. The Heinz body test was 
positive: 359/o (normal range: 20 f 5). 
Oxygen binding properties of the purified Hb 
Kariya were compared with those of Hb A (fig. 2). 
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Fig. 1. IEF of the hemolysates. 
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Fig. 2. Oxygen dissociation curves of Hb Kariya and 
Hb A. 
Hb Kariya shows an increase in oxygen affinity, 
decreased heme-heme interaction and diminution 
of 2,3-DPG effect. These experiments indicated 
that Hb Kariya has a normal alkaline Bohr effect. 
However, the most recent experiments indicate 
that the Bohr effect is somewhat decreased in Hb 
Kariya (not shown). 
Urea-dissociation electrophoresis of globin 
chains from Hb Kariya unravelled the presence of 
an abnormal a chain (aKa). The fingerprint of the 
soluble fraction of the tryptic digest of the purely 
isolated CY ICa chain disclosed the absence of aT-5, 
CUT-50x and aT-6 peptides at the proper sites and 
the presence of a new abnormal spot at the neutral 
zone on the map (fig. 3), suggesting a substitution 
of the C-terminal Lys ((r40) of aT-5 peptide. The 
amino acid composition of this peptide (table 1) 
was consistent with substitution of Lys --* Glx in 
the (~40 position. The fact that Glx at ~40 is Glu 
will be deduced by the electrophoretic property of 
this abnormal hemoglobin. Accordingly, Hb Kariya 
is an abnormal hemoglobin [cu40 (C5) Lys + Glu], 
which has not yet been recorded. 
4, DISCUSSION 
The Lys at the 40th position of the a-chain is in 
the C@Z contact. Its c-amino group forms a salt 
bridge with the e-carboxyl group of the C-terminal 
His residue of the P chain, and plays a very impor- 
Electrophoresis - 
Fig. 3. Fingerprint of the soluble fraction of the tryptic 
digest of the wKa chain: (I::) missing spots; (-) 
abnormal spot. 
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Table 1 
Amino acid composition of abnormal peptide 
Found (mol. ratio) aAT 5-6 
LYS 0.84 2 
His I.ss 2 
Asp 1.17 1 
Thr 3.02 3 
Ser 3.09 3 
Glu 2.01 I 
Pro 1.88 2 
Gly 1.07 1 
Ala 1.12 1 
Val 1.06 1 
Meta 0.60 1 
Leu 2.23 2 
Tyr 0.82 1 
Phe 3.72 4 
a N-terminal residue 
tant role in controlling the oxygen affinity by stabi- 
lizing the T quaternary structure [l 11. In Hb 
Kariya this salt bridge will be absent due to the 
replacement of Lys + Glu, resulting in the destabi- 
lization of the T structure and displacement of the 
T P R equilibrium toward the R state. The in- 
creased oxygen affinity and decreased heme-heme 
interaction of Hb Kariya can be understood on this 
basis. A similar mechamism causing high oxygen 
affinity is seen in the abnormal hemoglobins 
possessing amino acid substitution at the C-termi- 
nus of the@ chain (,&146), such as Hb Hiroshima 
(His + Asp) 1121, Hb York (His + Pro) [13], and 
Hb Cowtown (His + Leu) [14]. The reduced 
2,3-DPG effect observed in Hb Kariya may be ex- 
plained by assuming partial inhibition of the T-R 
transition upon oxygenation since the DPG 
binding depends on the quaternary structure [ 1 I]. 
Notwithstanding the high oxygen affinity of Hb 
Kariya, its carrier did not show any sign of poly- 
cythemia. The low percentage of the variant in the 
circulating blood (some of it possibly due to its in- 
stability) may not be adequate to cause a poly- 
cythemic response. 
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